Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eighteen analysts that are presently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $45.06.
BBWI has been the topic of a number of recent analyst reports. Raymond James reaffirmed an “outperform” rating and set a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Barclays dropped their price objective on shares of Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating for the company in a research report on Monday. JPMorgan Chase & Co. set a $47.00 price objective on shares of Bath & Body Works in a research report on Thursday. Piper Sandler increased their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Finally, Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $42.00 to $48.00 in a research report on Friday, January 10th.
View Our Latest Analysis on Bath & Body Works
Institutional Inflows and Outflows
Bath & Body Works Stock Down 2.3 %
NYSE:BBWI opened at $35.38 on Tuesday. The company has a market cap of $7.66 billion, a P/E ratio of 8.63, a P/E/G ratio of 0.92 and a beta of 1.83. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm’s 50 day moving average is $37.63 and its two-hundred day moving average is $34.17.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Research analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date is Friday, February 21st. Bath & Body Works’s payout ratio is 21.98%.
Bath & Body Works declared that its Board of Directors has authorized a stock buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in shares. This buyback authorization authorizes the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Further Reading
- Five stocks we like better than Bath & Body Works
- How to Calculate Inflation Rate
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Profitably Trade Stocks at 52-Week Highs
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- About the Markup Calculator
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.